Dundee Corp DDEJF

TauRx update from Genting site

[pierrelebel]

"UK National Health System has scheduled a meeting in 12 February 2025 (publication in April) to discuss adoption of HMTM into the public health system.

UK public health system offers nearly universal coverage, with over 98% of the population eligible for healthcare services free at the point of use. Therefore an adoption may lead to 1 million HMTM users fairy rapidly. At this point, pricing has been mutually agreed upon at GBPxxxx (USDxxxx) per patient per year. That works out to expected revenue of USDxbillion per annum.

I have again overestimated "western efficiency" in this instance. Full data was submitted in June 2024. MHRA "supposed" to give answer within 150 days (which works out to be end November 2024). Apparently the 150 days is not a "hard commitment". Feedback is that the process is expected to be completed only in February next year. Apologies if we can't celebrate before Christmas..."

As it turns out, we had this information on this board a month ago!

[TheCount11]

Thanks for update!

[Catscratch]

Is there a link for this?  I didn't see it on Genting's website.

[pierrelebel]

Hi Catscratch. Sorry, wrong choice of words, my bad,  I am referring to the Genting discussion board, through I3 investor. Genting is the largest shareholder of TauRx (about 20%+) These posters - at times - seem well informed yet there is a lot of in-fighting and nonsense. For example today: Dont bother with TauRx - got hundreds other alzheimer med under Phase 2/3 clinical trials Current

[Catscratch]

Thanks.  I've been following that message board as well and it does appear that there is at least one individual who is a direct TauRx shareholder.  Hopefully he is right about the likelihood of approval in UK.